Identifying novel targets to extend human healthspan

Systematic Medicines mission is to identify novel targets and therapeutic strategies to modulate the root causes of the ageing process. Our core differentiators from other ageing startups are:

• Funding model allows long term strategy. We are fully funded by our parent company Leading Technology Group (LTG), allowing us to pursue the science with the best long term potential, rather than the hot topic of the day.

• Scientific rigor. Good experimental design and statistical analysis is at the core of all our research.

• LTGs expertise. Our sister companies bring deep expertise in clinical trials and translational research.